Haplotype analysis of CYP11b2

Perrin C. White, Liliya Slutsker

Research output: Contribution to journalArticle

179 Citations (Scopus)

Abstract

Polymorphisms affecting the synthesis of aldosterone or its regulation may have effects on blood pressure. For example, an autosomal dominant form of human hypertension, glucocorticoid suppressible hyperaldosteronism, is caused by recombination between the genes for aldosterone synthase (CYP11B2) and steroid 11βhydroxylase (CYP11B1), creating a chimeric gene in which the CYP11B1 promoter and CYP11B2-specific coding sequences are juxtaposed. Thus, aldosterone synthesis is improperly regulated. We have begun an analysis of the human CYP11B2 and CYP11B1 genes to see if frequent polymorphisms exist and if they are correlated with differences in blood pressure. We have found frequent polymorphisms in CYP11B2. One in the promoter influences binding of the transcriptional regulatory protein, SF-1. Another is a gene conversion in intron 2 so that most of the intron has a sequence corresponding to CYP11B1. These polymorphisms are in linkage disequilibrium, defining 3 haplotypes. Blacks and whites differ significantly (p< 0.001) in the frequency with which these haplotypes occur. Further studies are required to determine if the observed differences between blacks and whites in blood pressure and in aldosterone levels can be explained in part by these allelic differences in CYP11B2 or by other polymorphisms in linkage disequilibrium on these haplotypes.

Original languageEnglish (US)
Pages (from-to)437-442
Number of pages6
JournalEndocrine Research
Volume21
Issue number1-2
DOIs
StatePublished - 1995

Fingerprint

Cytochrome P-450 CYP11B2
Haplotypes
Aldosterone
Steroids
Linkage Disequilibrium
Blood Pressure
Introns
Genes
Gene Conversion
Genetic Recombination
Hypertension

ASJC Scopus subject areas

  • Endocrinology

Cite this

Haplotype analysis of CYP11b2. / White, Perrin C.; Slutsker, Liliya.

In: Endocrine Research, Vol. 21, No. 1-2, 1995, p. 437-442.

Research output: Contribution to journalArticle

White, Perrin C. ; Slutsker, Liliya. / Haplotype analysis of CYP11b2. In: Endocrine Research. 1995 ; Vol. 21, No. 1-2. pp. 437-442.
@article{8d0ce42a29c7466d96b39ed9fc9addea,
title = "Haplotype analysis of CYP11b2",
abstract = "Polymorphisms affecting the synthesis of aldosterone or its regulation may have effects on blood pressure. For example, an autosomal dominant form of human hypertension, glucocorticoid suppressible hyperaldosteronism, is caused by recombination between the genes for aldosterone synthase (CYP11B2) and steroid 11βhydroxylase (CYP11B1), creating a chimeric gene in which the CYP11B1 promoter and CYP11B2-specific coding sequences are juxtaposed. Thus, aldosterone synthesis is improperly regulated. We have begun an analysis of the human CYP11B2 and CYP11B1 genes to see if frequent polymorphisms exist and if they are correlated with differences in blood pressure. We have found frequent polymorphisms in CYP11B2. One in the promoter influences binding of the transcriptional regulatory protein, SF-1. Another is a gene conversion in intron 2 so that most of the intron has a sequence corresponding to CYP11B1. These polymorphisms are in linkage disequilibrium, defining 3 haplotypes. Blacks and whites differ significantly (p< 0.001) in the frequency with which these haplotypes occur. Further studies are required to determine if the observed differences between blacks and whites in blood pressure and in aldosterone levels can be explained in part by these allelic differences in CYP11B2 or by other polymorphisms in linkage disequilibrium on these haplotypes.",
author = "White, {Perrin C.} and Liliya Slutsker",
year = "1995",
doi = "10.3109/07435809509030459",
language = "English (US)",
volume = "21",
pages = "437--442",
journal = "Endocrine Research",
issn = "0743-5800",
publisher = "Informa Healthcare",
number = "1-2",

}

TY - JOUR

T1 - Haplotype analysis of CYP11b2

AU - White, Perrin C.

AU - Slutsker, Liliya

PY - 1995

Y1 - 1995

N2 - Polymorphisms affecting the synthesis of aldosterone or its regulation may have effects on blood pressure. For example, an autosomal dominant form of human hypertension, glucocorticoid suppressible hyperaldosteronism, is caused by recombination between the genes for aldosterone synthase (CYP11B2) and steroid 11βhydroxylase (CYP11B1), creating a chimeric gene in which the CYP11B1 promoter and CYP11B2-specific coding sequences are juxtaposed. Thus, aldosterone synthesis is improperly regulated. We have begun an analysis of the human CYP11B2 and CYP11B1 genes to see if frequent polymorphisms exist and if they are correlated with differences in blood pressure. We have found frequent polymorphisms in CYP11B2. One in the promoter influences binding of the transcriptional regulatory protein, SF-1. Another is a gene conversion in intron 2 so that most of the intron has a sequence corresponding to CYP11B1. These polymorphisms are in linkage disequilibrium, defining 3 haplotypes. Blacks and whites differ significantly (p< 0.001) in the frequency with which these haplotypes occur. Further studies are required to determine if the observed differences between blacks and whites in blood pressure and in aldosterone levels can be explained in part by these allelic differences in CYP11B2 or by other polymorphisms in linkage disequilibrium on these haplotypes.

AB - Polymorphisms affecting the synthesis of aldosterone or its regulation may have effects on blood pressure. For example, an autosomal dominant form of human hypertension, glucocorticoid suppressible hyperaldosteronism, is caused by recombination between the genes for aldosterone synthase (CYP11B2) and steroid 11βhydroxylase (CYP11B1), creating a chimeric gene in which the CYP11B1 promoter and CYP11B2-specific coding sequences are juxtaposed. Thus, aldosterone synthesis is improperly regulated. We have begun an analysis of the human CYP11B2 and CYP11B1 genes to see if frequent polymorphisms exist and if they are correlated with differences in blood pressure. We have found frequent polymorphisms in CYP11B2. One in the promoter influences binding of the transcriptional regulatory protein, SF-1. Another is a gene conversion in intron 2 so that most of the intron has a sequence corresponding to CYP11B1. These polymorphisms are in linkage disequilibrium, defining 3 haplotypes. Blacks and whites differ significantly (p< 0.001) in the frequency with which these haplotypes occur. Further studies are required to determine if the observed differences between blacks and whites in blood pressure and in aldosterone levels can be explained in part by these allelic differences in CYP11B2 or by other polymorphisms in linkage disequilibrium on these haplotypes.

UR - http://www.scopus.com/inward/record.url?scp=0029020640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029020640&partnerID=8YFLogxK

U2 - 10.3109/07435809509030459

DO - 10.3109/07435809509030459

M3 - Article

C2 - 7588407

AN - SCOPUS:0029020640

VL - 21

SP - 437

EP - 442

JO - Endocrine Research

JF - Endocrine Research

SN - 0743-5800

IS - 1-2

ER -